GLP-1 use reaches new high in US

The percentage of US citizens currently taking GLP-1 drugs such as Wegovy for weight loss has almost quadrupled to 11% from 3% in 2024.

Archive

This is a stored Optics snapshot.It preserves the source map and wording analysis from 7/9/2026, 2:27:53 AM.

30-SECOND READ

What happenedThe percentage of US citizens currently taking GLP-1 drugs such as Wegovy for weight loss has almost quadrupled to 11% from 3% in 2024.

What changedThe headlines are mostly aligned. The differences are small wording choices, not a major framing split.

ConfidenceNeeds review. Single-source item awaiting a match.

Archive healthEarly pickup · awaiting comparison

WORDING GAP

0WORDING GAP

1 sources · 1 bias buckets · Needs review confidence

Mostly same. The outlets agree on the core event. The headlines are mostly aligned. The differences are small wording choices, not a major framing split.

SOURCE MAP TIMELINE

Jul 8, 10:46 PM: Semafor joined the source map.

Now: score hidden until the source match is cleaner. Story health is early pickup · awaiting comparison.

ARCHIVED SOURCES

Center ·News report

Semafor2h ago

GLP-1 use reaches new high in US

The percentage of US citizens currently taking GLP-1 drugs such as Wegovy for weight loss has almost quadrupled to 11% from 3% in 2024.

Open source